glp-1 gip news The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Obesity drugs regulate neural systems

US$ 22.64

★★★★★ 4.7 (23 reviews)

US$ 20.66

★★★★★ 4.2 (18 reviews)

US$ 22.59

★★★★★ 4.1 (14 reviews)

US$ 28.45

★★★★★ 4.3 (25 reviews)

US$ 25.71

★★★★★ 4.4 (7 reviews)

US$ 23.70

★★★★★ 4.6 (28 reviews)

US$ 23.28

★★★★★ 4.9 (15 reviews)

US$ 27.19

★★★★★ 4.7 (16 reviews)

US$ 28.69

★★★★★ 4.1 (25 reviews)

US$ 28.19

★★★★★ 4.3 (22 reviews)

US$ 25.45

★★★★★ 5.0 (29 reviews)

US$ 21.63

★★★★★ 4.9 (7 reviews)

US$ 23.05

★★★★★ 4.2 (24 reviews)

US$ 22.04

★★★★★ 4.1 (21 reviews)

US$ 20.44

★★★★★ 4.8 (13 reviews)

US$ 25.81

★★★★★ 4.8 (10 reviews)

US$ 28.13

★★★★★ 5.0 (12 reviews)

US$ 24.63

★★★★★ 4.1 (10 reviews)

US$ 26.67

★★★★★ 4.2 (23 reviews)

US$ 20.92

★★★★★ 4.9 (20 reviews)